Articles from Alcon Inc. Corporate

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’ unmet needs.5¤

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity® Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof® IQ Vivity® or AcrySof® IQ Vivity® Toric presbyopia-correcting intraocular lens (PCIOL). Data from more than 900 cataract patients demonstrated sustained clinical performance, high patient satisfaction and reduced dependence upon spectacles (glasses). Evidence also suggested that AcrySof® IQ Vivity® can be used successfully in a broad range of patients, providing surgeons and patients with additional treatment options.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will present a robust lineup of scientific data at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), happening 8-12 Sept. in Vienna, Austria. Alcon will showcase product updates that deliver patient outcomes and operational efficiencies for ophthalmologists and staff, and host events with surgeons sharing their real-world experiences with Alcon’s innovation, at booth #B201. For every attendee’s badge scanned at the Alcon booth, Alcon will further its commitment to environmental sustainability by funding the collection and recycling of 50 plastic bottles in coastal communities as part of its ongoing Plastic Bank partnership. Alcon ESCRS event information and registration is available at MyAlconatESCRS.com.

Working together to make a brilliant impact in the communities where they live and work, thousands of Alcon associates from 57 locations around the world are participating in Alcon in Alcon (AiA), a company-wide volunteering initiative. AiA expands Alcon’s year-round focus on increasing access to quality eye care and is an element of Alcon’s overall social impact and sustainability strategy which focuses on three pillars: Brilliant Lives, Brilliant Innovation and Brilliant Planet.

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards. Launched in 2021 by The Webby Awards, The Anthem Award winners are selected by the International Academy of Digital Arts and Sciences.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will unveil its latest innovations and expansive suite of vision care products at the SECO International meeting in Atlanta, Georgia. Alcon will debut TOTAL30® for Astigmatism, the first and only reusable Water Gradient toric lens on the market,1 now available to Eye Care Professionals (ECPs) across the U.S. In addition to showcasing its latest innovations, Alcon will present its newest clinical data and research findings across its vision care, dry eye, allergy and ocular health portfolios.

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with Cooper Kupp, professional football wide receiver and MVP of the “Big Game,” to share his experience with eye allergies and help other eye allergy sufferers find relief with Pataday® Once Daily Relief Extra Strength. This year’s campaign, The Right Tool for the Job, highlights Kupp’s personal struggle to find the right product to treat his eye allergy symptoms and how Pataday has delivered fast-acting, long-lasting, and targeted relief for his itchy allergy eyes on and off the field.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced key data that will be presented at this year’s American Society of Cataract and Refractive Surgery (ASCRS) meeting on its SMART Solutions for cataract surgery. SMARTCataract is the first application in Alcon’s comprehensive cloud-based platform uniquely designed for surgical ophthalmic practices. 2-6 The data shows significant time savings delivered during the cataract evaluation, planning process, operating room (OR) and postoperative (post-op) workflow for cataract patients.1

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with actress Kate Walsh, best known for her roles in Grey’s Anatomy and Emily in Paris, to share her journey with dry eye around the launch of its Systane® Complete Preservative-Free Lubricant Eye Drops. As part of the new Make Every Look Count campaign, Walsh will provide her personal testimonial about how her dry eye symptoms have impacted important moments – on- and off-screen – and how finding real relief with Systane has helped her reconnect to what matters most.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with actress Kate Walsh, best known for her roles in Grey’s Anatomy and Emily in Paris, to share her journey with dry eye around the launch of its Systane® Complete Preservative-Free Lubricant Eye Drops. As part of the new Make Every Look Count campaign, Walsh will provide her personal testimonial about how her dry eye symptoms have impacted important moments – on- and off-screen – and how finding real relief with Systane has helped her reconnect to what matters most.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will feature its latest advancement in integrated and connected surgical technologies – SMART Solutions by Alcon, a digital platform uniquely designed for ophthalmology – at the upcoming American Academy of Ophthalmology (AAO) 2021 annual meeting. This new platform furthers Alcon’s leadership in clinic-to-operating room (OR) integration with image-guided technologies and cloud-based planning. Key data on leading surgical equipment, ARGOS® Biometer with Image Guidance and Optiwave Refractive Analysis (ORA) SYSTEM®, will also be presented at the meeting.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will showcase leading innovations and clinical research findings at the American Academy of Optometry Annual Meeting (#Academy21) in Boston, Massachusetts, from November 3-6, 2021. The meeting will mark the official launch of TOTAL30®, the first-and-only monthly replacement Water Gradient contact lens that feels like nothing even on day 30,1 to the professional eye care community. Alcon’s engaging on-site program will feature events and more than a dozen clinical presentations around their most important eye care products, including the portfolio of permanent water surface technology contact lenses, dry eye and ocular health drops, and forthcoming innovations.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today celebrates World Sight Day 2021 by taking action in communities across the globe to raise awareness of blindness and vision impairment as global public health issues. Celebrated annually in October, World Sight Day is coordinated by the International Agency for the Prevention of Blindness (IAPB). This year’s theme, #LoveYourEyes, is all about being aware of your own eye health and the importance of regular, comprehensive eye exams for you and your loved ones.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has been recognized as a recipient of the FutureEdge 50 Award from International Data Group (IDG). This prestigious award is bestowed upon organizations for pushing the edge with innovative technologies to advance their business for the future.